Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: Where are they really located?
Jc. Reubi et al., Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: Where are they really located?, INT J CANC, 81(3), 1999, pp. 376-386
Receptors for cholecystokinin (CCK), gastrin, neurotensin, somatostatin and
vasoactive intestinal peptide (VIP) are over-expressed in several human tu
mors, where they have diagnostic and therapeutic implications. Since report
s on the expression of these peptide receptors in primary gastric and colon
ic adenocarcinomas are either non-existent or conflicting, a detailed evalu
ation with particular emphasis on the tissue localization was undertaken. C
CK-A, CCK-B, neurotensin, somatostatin and VIP receptors were localized by
in vitro receptor autoradiography with iodinated radioligands on histologic
al sections of surgical samples of 27 gastric and 25 colonic adenocarcinoma
s. CCK-A, CCK-B and neurotensin-l receptors were found in a minority of bot
h tumor types. Somatostatin receptors were found in 18/27 gastric and 2/25
colonic cancers. VIP receptors were found in 14/26 gastric and 23/25 coloni
c cancers; subtype characterization suggests VIPI receptors, In addition, r
esected tumor samples contained non-malignant tissues (mucosa, smooth muscl
e, nerves or vessels) with high amounts of the various peptide receptors, T
herefore, regulatory peptide receptors are expressed differentially in gast
ric and colonic cancers but also very frequently in "contaminating" non-mal
ignant tissues. Since results using morphological techniques are superior t
o those using homogenates, we recommend that localization of these receptor
s to the tissues should always be attempted, to minimize receptor over-esti
mation in tumors and to prevent spurious results. (C) 1999 Wiley-Liss, Inc.